- Home
- GNLX vs FONR Comparison
GNLX vs FONR Comparison
Compare GNLX & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- FONR
- Stock Information
- Founded
- GNLX 2001
- FONR 1978
- Country
- GNLX United States
- FONR United States
- Employees
- GNLX N/A
- FONR N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GNLX Health Care
- FONR Health Care
- Exchange
- GNLX Nasdaq
- FONR Nasdaq
- Market Cap
- GNLX 94.0M
- FONR 77.1M
- IPO Year
- GNLX 2023
- FONR 1987
- Fundamental
- Price
- GNLX $2.45
- FONR $14.50
- Analyst Decision
- GNLX Strong Buy
- FONR
- Analyst Count
- GNLX 4
- FONR 0
- Target Price
- GNLX $17.75
- FONR N/A
- AVG Volume (30 Days)
- GNLX 159.0K
- FONR 42.9K
- Earning Date
- GNLX 05-06-2025
- FONR 05-15-2025
- Dividend Yield
- GNLX N/A
- FONR N/A
- EPS Growth
- GNLX N/A
- FONR N/A
- EPS
- GNLX N/A
- FONR 1.28
- Revenue
- GNLX N/A
- FONR $103,018,089.00
- Revenue This Year
- GNLX N/A
- FONR N/A
- Revenue Next Year
- GNLX N/A
- FONR N/A
- P/E Ratio
- GNLX N/A
- FONR $11.36
- Revenue Growth
- GNLX N/A
- FONR 0.29
- 52 Week Low
- GNLX $1.60
- FONR $12.00
- 52 Week High
- GNLX $5.89
- FONR $18.68
- Technical
- Relative Strength Index (RSI)
- GNLX 44.96
- FONR 67.86
- Support Level
- GNLX $2.42
- FONR $14.20
- Resistance Level
- GNLX $2.78
- FONR $14.59
- Average True Range (ATR)
- GNLX 0.21
- FONR 0.57
- MACD
- GNLX 0.00
- FONR 0.16
- Stochastic Oscillator
- GNLX 28.30
- FONR 94.30
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.